A detailed history of Wells Fargo & Company transactions in Generation Bio Co. stock. As of the latest transaction made, Wells Fargo & Company holds 26,077 shares of GBIO stock, worth $62,063. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,077
Previous 20,372 28.0%
Holding current value
$62,063
Previous $82,000 10.98%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.64 - $4.35 $15,061 - $24,816
5,705 Added 28.0%
26,077 $73,000
Q1 2024

May 10, 2024

BUY
$1.73 - $4.07 $3,553 - $8,359
2,054 Added 11.21%
20,372 $82,000
Q4 2023

Feb 09, 2024

BUY
$0.91 - $3.35 $4,145 - $15,262
4,556 Added 33.11%
18,318 $30,000
Q3 2023

Nov 13, 2023

SELL
$3.65 - $6.9 $20,593 - $38,929
-5,642 Reduced 29.08%
13,762 $52,000
Q2 2023

Aug 15, 2023

BUY
$3.5 - $5.67 $30,649 - $49,652
8,757 Added 82.25%
19,404 $106,000
Q1 2023

May 12, 2023

BUY
$3.61 - $7.01 $30,854 - $59,914
8,547 Added 407.0%
10,647 $45,000
Q4 2022

Feb 13, 2023

SELL
$3.66 - $6.77 $431 - $798
-118 Reduced 5.32%
2,100 $8,000
Q3 2022

Nov 14, 2022

SELL
$4.68 - $8.34 $2,134 - $3,803
-456 Reduced 17.05%
2,218 $12,000
Q2 2022

Aug 12, 2022

SELL
$4.87 - $9.41 $16,713 - $32,295
-3,432 Reduced 56.21%
2,674 $18,000
Q1 2022

May 16, 2022

SELL
$4.16 - $7.76 $58,269 - $108,694
-14,007 Reduced 69.64%
6,106 $45,000
Q4 2021

Feb 14, 2022

BUY
$5.99 - $24.97 $116,367 - $485,092
19,427 Added 2831.92%
20,113 $143,000
Q3 2021

Nov 15, 2021

BUY
$20.0 - $27.43 $10,000 - $13,715
500 Added 268.82%
686 $17,000
Q2 2021

Aug 16, 2021

SELL
$24.34 - $38.34 $76,963 - $121,231
-3,162 Reduced 94.44%
186 $5,000
Q1 2021

May 13, 2021

SELL
$24.74 - $40.2 $89,633 - $145,644
-3,623 Reduced 51.97%
3,348 $95,000
Q4 2020

Feb 09, 2021

SELL
$21.68 - $51.61 $52,595 - $125,205
-2,426 Reduced 25.82%
6,971 $198,000
Q3 2020

Nov 05, 2020

BUY
$18.07 - $31.84 $169,803 - $299,200
9,397 New
9,397 $291,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $140M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.